First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

Abstract

The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients' high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft valve to treat severe TR. (<b>Level of Difficulty: Advanced.</b>).